WAY208466 inhibits glutamate release at hippocampal nerve terminals

European Journal of Pharmacology

Volumn 781, Issue , 2016, Pages 117-127

  Wang, Hue Yu ^a,b   Lu, Cheng Wei ^c,d   Lin, Tzu Yu ^c,d   Kuo, Jinn Rung ^a,e   Wang, Su Jane ^f  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

5 HT6 receptor; Antidepressant; Glutamate; Hippocampus; Synaptosomes; WAY208466

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAMPRIDINE; GLUTAMIC ACID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERTUSSIS TOXIN; SB 258585; SEROTONIN 6 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; WAY 208466; CACNA1B PROTEIN, RAT; CALCIUM; METHYLAMINE; N-(2-(3-(3-FLUOROPHENYLSULFONYL)-1H-PYRROLO(2,3-B)PYRIDIN-1-YL)ETHYL)-N,N-DIMETHYLAMINE; PYRIDINE DERIVATIVE; VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE);

ADULT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN SYNAPTOSOME; CALCIUM TRANSPORT; CONTROLLED STUDY; DEPRESSION; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE EXCITABILITY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; CYTOSOL; DRUG EFFECTS; EXOCYTOSIS; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

4-AMINOPYRIDINE; ADENYLYL CYCLASES; ANIMALS; CALCIUM; CALCIUM CHANNELS, N-TYPE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; EXOCYTOSIS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; METHYLAMINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SYNAPTOSOMES;

EID: 84963945172     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.04.010     Document Type: Article

References (53)

1. Y. Ago, K. Yano, R. Araki, N. Hiramatsu, Y. Kita, T. Kawasaki, H. Onoe, S. Chaki, A. Nakazato, H. Hashimoto, A. Baba, K. Takuma, and T. Matsuda Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice Neuropharmacology 65 2013 29 38
2. K.E. Akerman, I.G. Scott, J.E. Heikkila, and E. Heinonen Ionic dependence of membrane potential and glutamate receptor-linked responses in synaptoneurosomes as measured with a cyanine dye, DiS-C2-(5) J. Neurochem. 48 1987 552 559
3. R.H. Belmaker, and G. Agam Major depressive disorder N. Engl. J. Med. 358 1998 55 68
4. M.J. Berridge Neuronal calcium signaling Neuron 21 1998 13 26
5. G. Bonanno, R. Giambelli, L. Raiteri, E. Tiraboschi, S. Zappettini, L. Musazzi, M. Raiteri, G. Racagni, and M. Popoli Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus J. Neurosci. 25 2005 3270 3279
6. D.A. Brown, and T.S. Sihra Presynaptic signaling by heterotrimeric G-proteins Handb. Exp. Pharmacol. 184 2008 207 260
7. G.V. Carr, L.E. Schechter, and I. Lucki Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats Psychopharmacology 213 2011 499 507
8. C.Y. Chang, T.Y. Lin, C.W. Lu, C.C. Wang, Y.C. Wang, S.S.P. Chou, and S.J. Su-Jane Wang Apigenin, a natural flavonoid, inhibits glutamate release in the rat hippocampus Eur. J. Pharmacol. 762 2015 72 81
9. M.G. Chheda, U. Ashery, P. Thakur, J. Rettig, and Z.H. Sheng Phosphorylation of snapin by PKA modulates its interaction with the SNARE complex Nat. Cell Biol. 3 2001 331 338
10. W. Danysz, and C.G. Parsons Glycine and N-methyl-d-asparate receptors: physiological significance and possible therapeutic applications Pharmacol. Rev. 50 1988 597 664
11. L. Deutschenbaur, J. Beck, A. Kiyhankhadiv, M. Muhlhauser, S. Borgwardt, M. Walter, G. Hasler, D. Sollberger, and U.E. Lang Role of calcium, glutamate and NMDA in major depression and therapeutic application Prog. Neuropsychopharmacol. Biol. Psychiatry 64 2016 325 333
12. A.M. Feyissa, W.L. Woolverton, J.J. Miguel-Hidalgo, Z. Wang, P.B. Kyle, G. Hasler, C.A. Stockmeier, A.H. Iyo, and B. Karolewicz Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 279 283
13. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
14. K. Hashimoto The role of glutamate on the action of antidepressants Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 1558 1568
15. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol. Psychiatry 62 2007 1310 1316
16. I. Herrero, and J. Sánchez-Prieto cAMP-dependent facilitation of glutamate release by beta-adrenergic receptors in cerebrocortical nerve terminals J. Biol. Chem. 271 1996 30554 30560
17. N.D. Iadarola, M.J. Niciu, E.M. Richards, J.L. Vande Voort, E.D. Ballard, N.B. Lundin, A.C. Nugent, R. Machado-Vieira, and C.A. Zarate Jr. Ketamine and other N-methyl-d-aspartate receptor antagonists in the treatment of depression: a perspective review Ther. Adv. Chronic Dis. 6 2015 97 114
18. E. Kucukibrahimogl, M.Z. Saygin, M. Caliskan, O.K. Kaplan, C. Unsal, and M.Z. Goren The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression Eur. J. Clin. Pharmacol. 65 2009 571 577
19. J. Levine, K. Panchalingam, A. Rapoport, S. Gershon, R.J. McClure, and J.W. Pettegrew Increased cerebrospinal fluid glutamate levels in depressed patients Biol. Psychiatry 47 2000 586 593
20. M. Li, J.W. West, R. Numann, B.J. Murphy, T. Scheuer, and W.A. Catterall Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase Science 261 1993 1439 1442
21. T.Y. Lin, T.T. Yang, C.W. Lu, and S.J. Wang Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 598 606
22. M. Maes, R. Verkerk, E. Vandoolaeghe, A. Lin, and S. Scharpe Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity Acta Psychiatr. Scand. 97 1998 302 308
23. 2+ J. Neurochem. 56 1991 86 94
24. M. Milanese, D. Tardito, L. Musazzi, G. Treccani, A. Mallei, T. Bonifacino, C. Gabriel, E. Mocaer, G. Racagni, M. Popoli, and G. Bonanno Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes BMC Neurosci. 14 2013 75
25. C. Millan, and J. Sanchez-Prieto Differential coupling of N- and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex Neurosci. Lett. 330 2002 29 32
26. M.J. Millan, P. Marin, J. Bockaert, and C.M. Ia Cour Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions Trends Pharmacol. Sci. 29 2008 4544 4564
27. H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C.R. Ashby Jr., and R. Kawahara Correlation between plasma levels of glutamate, alanine and serine with severity of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 1155 1158
28. F.J. Monsma Jr, Y. Shen, R.P. Ward, M.W. Hamblin, and D.R. Sibley Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs Mol. Pharmacol. 43 1993 320 327
29. L. Musazzi, G. Treccani, A. Mallei, and M. Popoli The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors Biol. Psychiatry 73 2013 1180 1188
30. D.G. Nicholls Presynaptic modulation of glutamate release Prog. Brain Res. 116 1998 15 22
31. D.G. Nicholls, and T.S. Sihra Synaptosomes possess an exocytotic pool of glutamate Nature 321 1986 772 773
32. D.G. Nicholls, T.S. Sihra, and J. Sanchez-Prieto Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry J. Neurochem. 49 1987 50 57
33. R.A. Nicoll The coupling neurotransmitter receptors to ion channels in the brain Science 241 1988 545 551
34. A. Nikiforuk, T. Kos, and A. Wesolowska The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration Psychopharmacology 217 2011 411 418
35. H. Rehm, and B.L. Tempel Voltage-gated K+channels of the mammalian brain FASEB J. 5 1991 164 170
36. J.C. Roberts, C. Reavill, S.Z. East, P.J. Harrison, S. Patel, C. Routledge, and R.A. Leslie The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabeled 5-HT6 receptor antagonist [125I]SB-258585 Brain Res. 934 2002 49 57
37. B.L. Roth, S.C. Craigo, M.S. Choudhary, A. Uluer, F.J. Monsma Jr., Y. Shen, H.Y. Meltzer, and D.R. Sibley Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors J. Pharmacol. Exp. Ther. 268 1994 1403 1410
38. G. Sanacora, G. Treccani, and M. Popol Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
39. F. Saudou, and R. Hen 5-hydroxytryptamine receptor subtypes: molecular and functional diversity Adv. Pharmacol. 30 1994 327 380
40. L.E. Schechter, Q. Lin, D.L. Smith, G. Zhang, Q. Shan, B. Platt, M.R. Brandt, L.A. Dawson, D. Cole, R. Bernotas, A. Robichaud, S. Rosenzweig-Lipson, and C.E. Beyer Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacology 33 2008 1323 1335
41. M. Sebben, H. Ansanay, J. Bockaert, and A. Dumuis 5-HT6 receptor positively coupled to adenylyl cyclase in striatal neurons in culture NeuroReport 5 1994 2553 2557
42. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release J. Biol. Chem. 267 1992 1983 1989
43. P. Svenningasson, E.T. Tzavara, H. Qi, R. Carruthers, J.M. Witkin, G.G. Nomikos, and P. Greengard Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation J. Neurosci. 27 2007 4201 4209
44. A. Tassone, G. Madeo, T. Schirinz, D. Vita, F. Puglisi, G. Ponterio, F. Borsini, A. Pisani, and P. Bonsi Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission Neuropharmacology 61 2011 632 637
45. 2+ and glutamate release J. Neurochem. 53 1989 1693 1699
46. E. Vazquez, and J. Sanchez-Prieto Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals Eur. J. Neurosci. 9 1997 2009 2018
47. C.C. Wang, J.R. Kuo, and S.J. Wang Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals Eur. J. Pharmacol. 734 2014 67 76
48. 2+ channels Synapse 48 2003 170 177
49. R.P. Ward, M.W. Hamblin, J.E. Lachowicz, B.J. Hoffman, D.R. Sibley, and D.M. Dorsa Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry Neuroscience 64 1995 1105 1111
50. A. Wesolowska Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data Pharmacol. Rep. 62 2010 564 577
51. P.J. West, V.R. Marcy, M.J. Marino, and H. Schaffhauser Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus Neuroscience 164 2009 692 701
52. M.L. Woolley, C.A. Marsden, and K.C. Fone 5-HT6 receptors Curr. Drug Targets CNS Neurol. Disord. 3 2004 59 79
53. H.M. Yun, and H. Rhim The serotonin-6-receptor as a novel therapeutic target Exp. Neurobiol. 20 2011 159 168